Scienture FY25 operating loss widens to $42.6 million; gross margin climbs 7,240 bps to 76.8%

Reuters03-30
Scienture FY25 operating loss widens to $42.6 million; gross margin climbs 7,240 bps to 76.8%
  • Scienture posted a net loss of $41.5 million for 2025, swinging from net income of $9.1 million.
  • Revenue more than tripled to $431,609.
  • Gross margin widened 72.4 percentage points to 76.8%.
  • Cash and cash equivalents climbed to about $6.7 million.
  • Management pointed to momentum for Arbli, while targeting a commercial launch of REZENOPY in Q2 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scienture Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603300807PRIMZONEFULLFEED9680626) on March 30, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment